Profilo
Judy Chou is currently President, Chief Executive Officer & Director at AltruBio, Inc. since 2020.
Former positions include Independent Director at Akero Therapeutics, Inc. from 2021 to 2025, Director & Member-Governors Board at Biocom, Inc. from 2019 to 2020, and Senior Vice President & Global Head-Biotech at Bayer Pharmaceuticals.
Education includes a doctorate from Yale University.
Posizioni attive di Judy Chou
| Società | Posizione | Inizio |
|---|---|---|
Altrubio, Inc.
Altrubio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunomodulators to target diseases of the immune system | Amministratore Delegato | 01/01/2020 |
Precedenti posizioni note di Judy Chou
| Società | Posizione | Fine |
|---|---|---|
| AKERO THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 09/12/2025 |
BIOCOM
BIOCOM Miscellaneous Commercial ServicesCommercial Services Provides scientific and technological services | Direttore/Membro del Consiglio | 19/11/2020 |
Bayer Pharmaceuticals
Bayer Pharmaceuticals Pharmaceuticals: MajorHealth Technology Operates as a pharmaceuticals company | Corporate Officer/Principal | - |
Formazione di Judy Chou
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Società collegate
| Aziende private | 5 |
|---|---|
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BIOCOM
BIOCOM Miscellaneous Commercial ServicesCommercial Services Provides scientific and technological services | Commercial Services |
Akero Therapeutics, Inc.
Akero Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for patients with metabolic diseases | Health Technology |
Altrubio, Inc.
Altrubio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunomodulators to target diseases of the immune system | Health Technology |
Bayer Pharmaceuticals
Bayer Pharmaceuticals Pharmaceuticals: MajorHealth Technology Operates as a pharmaceuticals company | Health Technology |
















